Dr. Reddy's Laboratories Limited (RDY)
NYSE: RDY · IEX Real-Time Price · USD
76.12
+0.71 (0.94%)
At close: Jul 2, 2024, 4:00 PM
76.08
-0.04 (-0.05%)
After-hours: Jul 2, 2024, 7:49 PM EDT
Dr. Reddy's Laboratories Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for RDY stock has a target of 81, which predicts an increase of 6.41% from the current stock price of 76.12.
Analyst Consensus: Buy
* Price targets were last updated on May 8, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for RDY is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $80 → $81 | Buy | Maintains | $80 → $81 | +6.41% | May 8, 2024 |
| Barclays | Barclays | Buy Maintains $75 → $80 | Buy | Maintains | $75 → $80 | +5.10% | Jan 29, 2024 |
| Barclays | Barclays | Buy Maintains $67 → $70 | Buy | Maintains | $67 → $70 | -8.04% | Jun 1, 2023 |
| Barclays | Barclays | Buy Maintains $66 → $67 | Buy | Maintains | $66 → $67 | -11.98% | Oct 31, 2022 |
| Barclays | Barclays | Buy Maintains $69 → $66 | Buy | Maintains | $69 → $66 | -13.29% | Oct 25, 2022 |
Financial Forecast
Revenue This Year
304.17B
from 279.16B
Increased by 8.96%
Revenue Next Year
321.42B
from 304.17B
Increased by 5.67%
EPS This Year
338.40
from 334.02
Increased by 1.31%
EPS Next Year
343.38
from 338.40
Increased by 1.47%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 330.0B | 363.2B | 370.6B | 398.5B |
| Avg | 304.2B | 321.4B | 324.4B | 372.7B |
| Low | 248.9B | 261.7B | 274.9B | 344.3B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 18.2% | 19.4% | 15.3% | 22.8% |
| Avg | 9.0% | 5.7% | 0.9% | 14.9% |
| Low | -10.8% | -14.0% | -14.5% | 6.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 399.00 | 435.96 | 370.68 |
| Avg | 338.40 | 343.38 | 295.66 |
| Low | 212.95 | 241.18 | 195.73 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 19.5% | 28.8% | 8.0% |
| Avg | 1.3% | 1.5% | -13.9% |
| Low | -36.2% | -28.7% | -43.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.